It is well documented that the Northeast State of Manipur in India has been dealing with the dual problems of injecting drug use and HIV for the last two decades, but the hepatitis C problem has not been so well characterized. The aim of this study was to assess the prevalence of hepatitis C virus (HCV) infection and HCV/HIV co-infection among people who inject drugs (PWID) in Manipur, and identify factors associated with infection.
People who inject drugs (PWID) are at particularly high risk of infection with hepatitis C virus (HCV) 1 , which is transmitted via exposure to infected blood during the act of injecting, not only through sharing needles and syringes but also other injecting equipment such as filters, spoons, mixing pots and swabs 2 . The prevalence of HCV infection among PWID is higher than that in HIV positive individuals because HCV is more efficiently transmitted from one person to another, and the pool of infected peers is generally large 1 . Of those infected with HCV, about 75 per cent become chronically infected, and of these, 7-18 per cent will develop cirrhosis over a 20 year period, and be at risk of hepatocellular carcinoma (1-6% per year) or liver failure (2-3% per year) 3 .
It is estimated that approximately 15 per cent of people infected with HIV are co-infected with HCV 4 . HCV/HIV co-infection can accelerate the progression of hepatitis C 5 , and co-infected people have shorter life expectancy than those with HIV alone 6 . HIV/HCV coinfection complicates anti-retroviral therapy (ART) for treatment of HIV infection, as several anti-retroviral drugs are poorly tolerated by co-infected patients. Early detection of co-infection is optimal so that HCV treatment can be commenced before initiation of ART 7 .
It is also the case that HCV treatment is less effective for HIV positive people 7 . Untill recently, the most common treatment regimen for HCV infection was pegylated interferon and ribavirin for up to 48 wk. A sustained virological response is possible for approximately 40 per cent of co-infected patients, which is 10-20 per cent lower than patients with HCV mono-infection 7 . The new direct acting antivirals (DAAs) are more effective, can treat more HCV serotypes, are administered orally for a shorter duration of treatment, and have fewer side effects 8, 9 . However, it is not clear if and how HCV-infected people in low and middle income countries will be able to access these life-saving therapies.
The prevalence of HCV infection in India is estimated to be between 0.5 and 1.5 per cent which is five times higher than the prevalence of HIV infection 10 . While there is no routine surveillance for HCV infection, a number of cross-sectional bio-surveys have been conducted revealing varying HCV prevalence among PWID in India depending on site and point in time 10 . Injecting illicit drugs, most commonly heroin, has played a prominent role in the HIV epidemic in the Northeast State of Manipur [11] [12] [13] [14] , which consistently reports the highest HIV prevalence in the country 15 . Less is known about hepatitis C and HCV/HIV coinfection in this State. Of the 250 PWID attending a de-addiction centre in Manipur screened in 2002 for HIV/HCV co-infection, 60 per cent were HIV positive, 90 per cent were HCV positive, and 52 per cent were co-infected 16 . The first round of the Avahan-funded This study aimed to describe the prevalence of HCV infection and HIV/HCV co-infection among PWID in Manipur, and identify factors associated with HCV infection and HCV/HIV co-infection. Sampling: Respondent driven sampling (RDS) was used to recruit study participants. In brief, RDS is a probability sampling method devised for more representative recruitment of hidden populations such as PWID 20 . It involves chain referral sampling that collects data on social network sizes and recruitment patterns to determine selection probabilities 21, 22 . For this study, a sample size of 400 per district was estimated based on an ability to detect changes in proportions of 15 per cent at follow up surveys from estimated baseline values of 50 per cent (which yield the biggest sample size), an alpha level of 0.05, and power of 90 per cent. A design effect of 1.5 was applied to account for intra-class correlation.
Material & Methods

Avahan
Data collection: A PWID was defined as any male, 18 yr or older, who had injected drugs for nonmedical reasons at least once in the past six months. An anonymous, interviewer-administered structured questionnaire was used to gather information regarding socio-demographic information, drug use, sexual and injecting risk behaviours, knowledge of HIV, and exposure to interventions. Additionally, biological specimens (blood and urine) were tested for a range of sexually transmitted infections (STIs) and HIV. Serum Statistical analysis: Data obtained using RDS sampling are usually analysed using RDS software (RDSAT) that generates appropriately weighted estimated proportions with confidence intervals. However, it is not possible to undertake bivariate or multivariate analysis using RDSAT, so the analyses presented here were undertaken using SPSS version 19.0 (SPSS, Inc., Chicago, USA). The Chi-square test was used to examine differences between categorical variables, and the independentsample t test for differences between continuous variables. Both bivariate and binary logistic regression analyses were conducted. The two outcomes of interest for the regression modelling were HCV infection and HCV/HIV co-infection. The covariates for each model were those significantly associated (P≤0.05) with the outcome variable on bivariate testing.
Results
The total number of participants was 821 (411 from Churachandpur and 410 from Bishnupur). The mean age was 29.8 ± 6.13 yr (range 18-55 yr). The majority (92.2%) were literate. Just over half (57.0%) were employed, 2.8 per cent were students and 40.2 per cent unemployed. Half of the participants (50.7%) had never been married, 37.8 per cent were currently married, and 11.6 per cent were widowed/divorced/ separated (Table I ). The majority of PWID (58.5%) were injecting at least once daily, and 97.1 per cent generally injected heroin. A little more than one quarter (26.8%) had begun injecting before 20 yr of age, but the majority (65.2%) commenced injecting between 20-29 yr. Half (51.7%) had been injecting for longer than five years. Sharing of injecting equipment was very common (82.8%), and half (50.4%) reported that they generally injected with a needle and syringe previously used by another (Table I ).
Major differences between the two districts were noted. Compared to participants from Bishnupur, participants from Churachandpur were more likely to be unemployed or students (59.6 vs. 26.4%); be widowed, separated or divorced ( (Table I) .
HCV infection and HCV/HIV co-infection:
The level of HCV infection was particularly high, and significant differences between the two districts were observed; 73.9 per cent of PWID tested positive for HCV (91.5% Churachandpur, 56.3% Bishnupur). HIV/ HCV co-infection was prevalent in 29. 4 
Factors associated with HCV infection: Infection with
HCV was significantly associated with district, older age, having ever been married, earlier age of first injection, longer duration of injecting, injecting at least once daily, generally sharing injecting equipment, generally injecting with a needle and syringe used by another, feeling at risk of HIV, and having ever had an HIV test (Table II) .
After controlling for confounding, district, duration and frequency of injecting, generally injecting with a needle and syringe used by another, and having ever had an HIV test remained independently associated with HCV infection. The PWID in Churachandpur were almost four times more likely to be infected with HCV compared to those in Bishnupur [odds ratio (OR)] 3.75; 95% confidence interval [(CI 2.22-6.35)]. Relative to those who had been injecting for two years or less, those who had been injecting for 6-10 yr were more than twice as likely to have HCV (OR 2.48; 95% CI 1.36-4.51); and those who had been injecting longer than 10 yr were more than five times as likely (OR 5.65; 95% CI 2.16-14.79). Those injecting at least once daily were four times more likely to be HCV infected than those who injected less frequently (OR 4.18; 95% CI 2.56-6.89). PWID who generally injected with a needle and syringe used by another were also at greater risk of HCV infection (OR 1.59; 95% CI 1.03-2.45), and those who ever had an HIV test were twice as likely compared to those who had never had one (OR 2.08; 95% CI 1.37-3.16) (Table II) . 
Factors associated with HIV/HCV co-infection:
Co-infection with HIV and HCV was significantly associated with district, older age, being employed, having ever been married, earlier age of first injection, longer duration of injecting, injecting at least once daily, generally sharing injecting equipment, generally injecting with a needle and syringe used by another, feeling at risk of HIV, having ever had an HIV test, and having ever been in prison (Table III) .
After controlling for confounding, district, age, being employed, marital status, duration of injecting and feeling at risk of HIV infection remained independently associated with HIV/HCV co-infection. The PWID in Churachandpur were more than two times more likely to be co-infected compared to those in Bishnupur (OR 2.35; 95% CI 1.42-3.90). PWID aged 30 yr or older were almost four times more likely to be co-infected relative to those aged less than 30 yr (OR 3.78; 95% CI 2.11-6.75), and the employed PWID were almost twice as likely to be co-infected compared to the unemployed/student group (OR 1.82; 95% CI 1.16-2.86). The widowed/divorced/separated PWID were twice as likely to have co-infection relative to those who were currently married (OR 2.15; 95% CI 1.17-3.94). Compared to those who had been injecting for two years or less, those who had been injecting for 6-10 yr were more than twice as likely to be coinfected (OR 2.60; 95% CI 1.22-5.53); and those who had been injecting longer than 10 yr were seven times more likely to be co-infected (OR 7.26; 95% CI 2.90-18.16). Those who felt at risk of HIV infection were four times more likely to be co-infected compared to those who did not feel at risk (OR 3.97; 95% CI 2.43-6.48) (Table III) .
Discussion
The results from this cross-sectional survey among a large group of PWID in two districts of Manipur indicated a high prevalence of infection with HCV, especially among those who are HIV infected. Of particular concern was the high prevalence of HCV infection among those who were HIV infected (95%), highlighting the importance of testing all HIV infected PWID for HCV before commencing ART. This finding was consistent with the 96 per cent of HIV positive PWID found to be co-infected with HCV in the neighbouring State of Mizoram, having similar patterns of drug use 23 .
The finding that HCV infection among these PWID is independently associated with longer duration of injecting, more frequent injecting and generally injecting with a needle and syringe used by another is not a surprising as all of these factors increase the odds of exposure to an HCV-infected peer over time, especially given that needle and syringe sharing remains common. The association between HCV 
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Variables HCV +ve n (%) infection and having ever had an HIV test is possibly explained by the fact that those who are HCV infected tend to be longer-term injectors, and as such are more likely to have had contact with a harm reduction programme, and these programmes facilitate uptake of HIV testing 24 . It would be optimal if all PWID who present for HIV testing are tested for HCV at the same time.
Longer duration of injecting was also independently associated with HIV/HCV co-infection, as was older age. The reason for the finding that employed PWID were more likely to be co-infected compared to those who were unemployed/students could be that employed PWID had more money and were therefore, able to inject more frequently and thus at greater risk of infection with a blood-borne virus. However, posthoc analysis did not support this hypothesis (70% unemployed/students vs. 50% employed injected at least once daily; P<0.001). Co-infection was also associated with being widowed/divorced/separated, which was possibly indicative of PWID coming from the more chronic end of the drug using spectrum, and therefore, more at risk of HCV infection. Perceiving oneself as being at risk of HIV infection could be a function of regular unsafe injecting behaviours that also place the person at risk of HCV infection. Posthoc analysis supported this contention (59% of those who felt at risk of HIV generally injected with a needle and syringe previously used by someone else vs. 35 % of those who did not feel at risk; P<0.001).
The relatively higher prevalence of HCV infection and HIV/HCV co-infection in Churachandpur compared to Bishnupur was not unexpected, and the difference was consistent with the Round 1 IBBA results 13 . HIV prevalence was also higher in Churachandpur, given that PWID in Churachandpur were engaged in much riskier injecting behaviours compared with their peers in Bishnupur, i.e. they were more likely to inject at least daily, share injecting equipment, and share a needle and syringe previously used by another.
This study had several limitations that should be considered when interpreting the findings. Due to the cross-sectional study design it was not possible to infer causation for outcome variables. Even though respondent driven sampling is probability based, the analyses for this study used unweighted data, and therefore, the representativeness of the sample is similar to that of a large snowball sample. Social acceptability bias may have contributed to an underestimate in the prevalence of unsafe injecting behaviours. Thoroughly mapping currently available HCV testing and treatment services relative to PWID populations, along with an investigation of knowledge and attitudes related to HCV prevention and treatment among PWID would provide a more complete picture of the situation to optimize the design of an evidence-based response.
The findings highlight high HCV positivity in PWID in one Northeast Indian State where prevention, diagnosis and treatment options are limited. It is highly probable that other States with injecting drug use problems are similarly affected. It was also evident that HCV infection was more common than HIV infection. It would be beneficial if all PWID who come for HIV testing are tested for HCV also at the same time. As ART coverage increases across India, untreated HCV infection may become the major health concern for many PWID.
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